Search Results - "Passik, Steven D"

Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline by Chou, Roger, Fanciullo, Gilbert J, Fine, Perry G, Miaskowski, Christine, Passik, Steven D, Portenoy, Russell K

“…Optimal methods to predict risk of aberrant drug-related behaviors before initiation of opioids for chronic noncancer pain and to identify aberrant behaviors…”
Get more information

Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain by Chou, Roger, Fanciullo, Gilbert J, Fine, Perry G, Adler, Jeremy A, Ballantyne, Jane C, Davies, Pamela, Donovan, Marilee I, Fishbain, David A, Foley, Kathy M, Fudin, Jeffrey, Gilson, Aaron M, Kelter, Alexander, Mauskop, Alexander, O'Connor, Patrick G, Passik, Steven D, Pasternak, Gavril W, Portenoy, Russell K, Rich, Ben A, Roberts, Richard G, Todd, Knox H, Miaskowski, Christine

“…Use of chronic opioid therapy for chronic noncancer pain has increased substantially. The American Pain Society and the American Academy of Pain Medicine…”
Get more information

Distress screening in a multidisciplinary lung cancer clinic: Prevalence and predictors of clinically significant distress by Graves, Kristi D, Arnold, Susanne M, Love, Celia L, Kirsh, Kenneth L, Moore, Pamela G, Passik, Steven D

“…Summary Screening for distress in cancer patients is recommended by the National Comprehensive Cancer Network, and a Distress Thermometer has previously been…”
Get full text

Aberrant Drug-Related Behavior Observed During Clinical Studies Involving Patients Taking Chronic Opioid Therapy for Persistent Pain and Fentanyl Buccal Tablet for Breakthrough Pain by Passik, Steven D., PhD, Messina, John, PharmD, Golsorkhi, Anthony, MD, Xie, Fang, PhD

“…Abstract Context Information on aberrant drug-related behaviors in the clinical study setting is limited. Objectives This retrospective analysis was designed…”
Get full text

Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion events by Jones, Ted, Moore, Todd M, Meske, Diana S, Passik, Steven D

“…The standard of care calls for the assessment of patients with chronic pain prior to the initiation of opioids, with one part of this assessment including…”
Get more information

A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study by Navari, Rudolph M, Einhorn, Lawrence H, Loehrer, Sr, Patrick J, Passik, Steven D, Vinson, Jake, McClean, John, Chowhan, Naveed, Hanna, Nasser H, Johnson, Cynthia S

“…The purpose of this study is to determine the control of acute and delayed chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately…”
Get full text

Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions by Passik, Steven D., PhD

“…Both chronic pain and prescription opioid abuse are prevalent and exact a high toll on patients, physicians, and society. Health care professionals must…”
Get full text

Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysis by Zah, Vladimir, Imro, Martina, Tatovic, Simona, DeGeorge, Michael, Passik, Steven D, Vukicevic, Djurdja

“…To compare concomitant benzodiazepine (BZDs) use among chronic pain patients adherent to extended-release tapentadol (TapER) or oxycodone (OxnER) and estimate…”
Get more information

A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier Oncology Group study by Navari, Rudolph M, Einhorn, Lawrence H, Passik, Steven D, Loehrer, Sr, Patrick J, Johnson, Cynthia, Mayer, M L, McClean, J, Vinson, Jake, Pletcher, W

“…In a previous phase I study, olanzapine was demonstrated to be a safe and effective agent for the prevention of delayed emesis in chemotherapy-naïve cancer…”
Get full text

Frequency, Characteristics, and Correlates of Pain in a Pilot Study of Colorectal Cancer Survivors 1–10 Years Post‐Treatment by Lowery, Amy E., Starr, Tatiana, Dhingra, Lara K., Rogak, Lauren, Hamrick‐Price, Julie R., Farberov, Maria, Kirsh, Kenneth L., Saltz, Leonard B., Breitbart, William S., Passik, Steven D.

“…Objective The long‐term effects of disease and treatment in colorectal cancer (CRC) survivors are poorly understood. This study examined the prevalence and…”
Get full text

Reality and responsibility revisited: Stakeholder accountability in the effort to develop safer opioids by Passik, Steven D, Heit, Howard A, DeGeorge, Michael

“…This supplement is dedicated to an exploration of the science, potential utility, and the current state of abuse-deterrent formulations (ADF) of opioid…”
Get more information

Issues in Long-term Opioid Therapy: Unmet Needs, Risks, and Solutions by PASSIK, Steven D

“…Both chronic pain and prescription opioid abuse are prevalent and exact a high toll on patients, physicians, and society. Health care professionals must…”
Get full text

Association of Patients' Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder by Pytell, Jarratt D, Whitley, Penn, Passik, Steven D, Bundy, William L, Dawson, Eric, Saloner, Brendan

“…The direct addition of buprenorphine to urine drug test specimens to mimic results suggestive of adherence is a clinically significant result, yet little is…”
Get more information

A comparison of methods of administering the opioid risk tool by Jones, Ted, Passik, Steven D

“…Risk assessment and stratification have become important aspects for the prescription of opioids to patients with chronic pain. Recent research has shown that…”
Get more information

Assessment of Quality of Life in Outpatients With Advanced Cancer: The Accuracy of Clinician Estimations and the Relevance of Spiritual Well-Being—A Hoosier Oncology Group Study by FISCH, Michael J, TITZER, Michael L, KRISTELLER, Jean L, JIANZHAO SHEN, LOEHRER, Patrick J, JUNG, Sin-Ho, PASSIK, Steven D, EINHORN, Lawrence H

“…To evaluate the association between quality-of-life (QOL) impairment as reported by patients and QOL impairment as judged by nurses or physicians, with and…”
Get full text

Sleep problems in breast cancer survivors 1-10 years posttreatment by Lowery-Allison, Amy E, Passik, Steven D, Cribbet, Matthew R, Reinsel, Ruth A, O'Sullivan, Barbara, Norton, Larry, Kirsh, Kenneth L, Kavey, Neil B

“…ABSTRACTObjective:Sleep can affect quality of life (QoL) during cancer survivorship, and symptoms related to poor sleep can be exacerbated. We examined the…”
Get more information

A Phase I Trial of Olanzapine (Zyprexa) for the Prevention of Delayed Emesis in Cancer Patients: A Hoosier Oncology Group Study by Passik, Steven D., Navari, Rudolph M., Jung, Sin-Ho, Nagy, Cindy, Vinson, Jake, Kirsh, Kenneth L., Loehrer, Patrick

“…Chemotherapy-induced delayed emesis (DE) can affect up to 50% to 70% of patients receiving moderately and highly emetogenic chemotherapy, although rates are…”
Get full text

An Analysis of the Root Causes for Opioid-Related Overdose Deaths in the United States by Webster, Lynn R., Cochella, Susan, Dasgupta, Nabarun, Fakata, Keri L., Fine, Perry G., Fishman, Scott M., Grey, Todd, Johnson, Erin M., Lee, Lewis K., Passik, Steven D., Peppin, John, Porucznik, Christina A., Ray, Albert, Schnoll, Sidney H., Stieg, Richard L., Wakeland, Wayne

“…Objective.  A panel of experts in pain medicine and public policy convened to examine root causes and risk factors for opioid‐related poisoning deaths and to…”
Get full text

Nonmedical Prescription Opioid Use for the Self-treatment of Pain in Young Adults: A National Shame by Passik, Steven D.

“…Evans et al. (2017) have pointed out how frequently and pervasively nonmedical prescription opioid use is associated with severe pain in young adults,…”
Get full text

Initial development of a survey tool to detect issues of chemical coping in chronic pain patients by Kirsh, Kenneth L, Jass, Carolyn, Bennett, Daniel S, Hagen, James E, Passik, Steven D

“…Completely compliant drug-taking behavior is associated with opioid therapy that is usually highly beneficial to the pain patient, whereas frequent and severe…”
Get more information